Joined Today: 0

DEPO Depomed, Stock Message Board

All Messages

DEPO Message Board Home | Join The DEPO Group |

#51: DEPO News Depomed Delivers Notice of Breach and Demand for Arbitration to Esprit Pharma
Stock News Bot	December 18, 2006 05:00:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced that it has delivered a notice to Esprit Pharma, Inc. regarding Esprit’s breaches of the... view message ignore post recommend post

#50: DEPO News Depomed Announces Equity Financing Commitment of Up to $30 Million
Stock News Bot	December 12, 2006 05:00:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced that it has received a commitment of up to $30 million in common stock equity financing from Azimuth... view message ignore post recommend post

#49: DEPO News Depomed Announces Strong Positive Phase II Trial Results for Once Daily Gabapentin GR(TM) to Treat Symptoms of Diabetic Peripheral Neuropathy
Stock News Bot	December 12, 2006 04:30:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (Nasdaq:DEPO) today announced statistically significant efficacy benefits of its Gabapentin GR™ extended release tablets for... view message ignore post recommend post

#48: DEPO News Depomed Comments on Today's Trading Activity
Stock News Bot	December 4, 2006 05:02:00 PM
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced that it is not aware of any new development related to the company’s business that would have... view message ignore post recommend post

#47: DEPO News New Patient Support Program Offers Savings on Glumetza(TM) Therapy for Type 2 Diabetes
Stock News Bot	November 21, 2006 05:31:00 AM
BRISTOL, Tenn. & MENLO PARK, Calif.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE: KG) and Depomed, Inc. (NASDAQ: DEPO) today announced the launch of a new program that will provide... view message ignore post recommend post

#46: DEPO News Depomed to Present at the Lazard Annual Life Sciences Conference
Stock News Bot	November 15, 2006 05:00:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced that chairman, president and chief executive officer, John W. Fara, Ph.D., will present on Wednesday, ... view message ignore post recommend post

#45: DEPO News Depomed Reports Third Quarter 2006 Financial Results
Stock News Bot	November 9, 2006 05:00:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced its financial results for the quarter ended September 30, 2006. For the quarter, a net loss of $12.6... view message ignore post recommend post

#44: DEPO News Depomed to Announce Third Quarter 2006 Financial Results on Thursday, November 9, 2006
Stock News Bot	October 26, 2006 01:00:00 PM
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced that it will release third quarter financial results for 2006 before the market opens on Thursday, ... view message ignore post recommend post

#43: DEPO News Depomed to Webcast Presentations at Two Healthcare Investment Conferences
Stock News Bot	October 26, 2006 05:00:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced that chairman, president and chief executive officer, John W. Fara, Ph.D., will present at two ... view message ignore post recommend post

#42: DEPO News Depomed Obtains Exclusive License to Gabapentin Use in Hot Flashes
Stock News Bot	October 18, 2006 12:00:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced that it has obtained an exclusive sublicense from PharmaNova, Inc. to a U.S. patent held by the ... view message ignore post recommend post

#41: DEPO News Depomed Completes Enrollment in Phase II Clinical Trial in Diabetic Peripheral Neuropathy With Gabapentin GR
Stock News Bot	October 5, 2006 05:00:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) today announced that it has completed enrollment in a Phase II clinical trial to evaluate its Gabapentin GR compound... view message ignore post recommend post

#40: DEPO News Depomed to Present at the UBS Global Life Sciences Conference
Stock News Bot	September 20, 2006 05:00:00 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--Sept. 20, 2006--Depomed, Inc. (NASDAQ:DEPO) today announced that chairman, president and chief executive officer, John W. Fara, Ph.D., will present on... view message ignore post recommend post

#39: DEPO News Depomed to Present at the Oppenheimer Diabetes Conference
Stock News Bot	September 18, 2006 01:00:00 PM
MENLO PARK, Calif.--(BUSINESS WIRE)--Sept. 18, 2006--Depomed, Inc. (NASDAQ:DEPO) today announced that chairman, president and chief executive officer, John W. Fara, Ph.D., will present on Thursday,... view message ignore post recommend post

#38: DEPO News New Once-Daily Oral Diabetes Treatment Glumetza(TM) Now Available
Stock News Bot	September 6, 2006 07:18:00 AM
BRISTOL, Tenn. & MENLO PARK, Calif.--(BUSINESS WIRE)--Sept. 6, 2006-- - Novel Drug-Delivery Technology Enables Extended-Release Formulation to Combine Efficacy Benefits of Metformin with... view message ignore post recommend post

#37: DEPO News Depomed to Present at the ThinkEquity Partners Growth Conference
Stock News Bot	September 5, 2006 01:00:00 PM
MENLO PARK, Calif.--(BUSINESS WIRE)--Sept. 5, 2006--Depomed, Inc. (NASDAQ:DEPO) today announced that chairman, president and chief executive officer, John W. Fara, Ph.D., will present on Wednesday,... view message ignore post recommend post

Group Home | Login if you want to post a message